The alpelisib (ALP) experience in the SOLAR-1 and BYLieve studies: Perspectives for practitioners caring for patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) Meeting Abstract


Authors: Rugo, H. S.; André, F.; Park, Y. H.; Drullinsky, P.; Loibl, S.; Cardoso, F.; Mason, G.; Aubel, D.; Lorenzo, I.; Akdere, M.; Ciruelos, E. M.
Abstract Title: The alpelisib (ALP) experience in the SOLAR-1 and BYLieve studies: Perspectives for practitioners caring for patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)
Meeting Title: Advanced Breast Cancer 6th International Consensus Conference (ABC6)
Journal Title: Breast
Volume: 59
Issue: Suppl. 1
Meeting Dates: 2021 Nov 4-6
Meeting Location: Virtual
ISSN: 0960-9776
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S49
Language: English
ACCESSION: WOS:000706614300059
PROVIDER: wos
DOI: 10.1016/S0960-9776(21)00547-6
Notes: Meeting Abstract: PO62 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors